According to the research report titled ‘Global Antibiotics Market - Analysis By Drug Class (Beta-Lactams, Cephalosporins, Lipopeptide, Others), Mechanism, By Region, By Country (2021 Edition): Market Insights and Forecast with Impact of COVID-19 (2021-2026)’, available with MarketStudyReport, global antibiotics market was worth USD 46.66 billion in 2020 and is anticipated to garner notable returns by the year 2026.

Report findings suggest that ever increasing elderly population around the world, rising technological advancements, and increased awareness of infectious diseases are propelling the global antibiotics market outlook.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4383307/

Notably, rising tendency of individuals overusing antibiotics is increasing the chance of citizens developing antimicrobial resistance, rendering current antibiotics useless against disease-causing bacteria. As a result, growing emphasize towards clinical research on new antibiotics as well as increasing product demand due to booming world population are boosting the industry trends.

Furthermore, antibiotics were provided to as much as 95 percent of those infected with the coronavirus during the outbreak. These included azithromycin and hydroxychloroquine among others, which were effective in treating virus infections, thereby creating a huge product demand, which has impelled the industry share.

Speaking of drug class, the industry is branched into lipopeptide, beta-lactams (penicillin), cephalosporins, and others. In terms of mechanism, the market is divided into DNA synthesis, protein synthesis, cell wall synthesis, and others.

Regionally speaking, North America market held a substantial revenue share in 2020 and is projected to grow significantly over the forecast timeline. Other geographies considered for studying industry trends include Europe (Italy, Spain, Germany, France, United Kingdom), LAMEA, and Asia Pacific (China, India, Japan).

Johnson & Johnson, F. Hoffmann-La Roche AG, Merck KGaA, Amgen Inc., Eli Lily and Company, Novartis International AG, GlaxoSmithKline plc, Pfizer Inc., Bayer AG, and Deinove SA are the leading players influencing the worldwide antibiotics market dynamics. The contenders are undertaking constant research & development for product innovations, and are entering into collaborations & partnerships to improve customer reach and strength their position.